Anticoagulation for stroke prevention: high effectiveness, more cost benefit?

Pharmacoeconomics. 2006;24(10):1035-8. doi: 10.2165/00019053-200624100-00010.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Cost-Benefit Analysis
  • Humans
  • International Normalized Ratio
  • Stroke / prevention & control*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin